Fig. 1From: Antibody and transcription landscape in peripheral blood mononuclear cells of elderly adults over 70 years of age with third dose of COVID-19 BBIBP-CorV and ZF2001 booster vaccineThe details of this study design, including age characteristics of participants, booster vaccine type, and samples collection time in the 4 booster groupsBack to article page